The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

Part of paid clinical trials in Worcester, Massachusetts.

Sponsor
MCPHS University
Study ID
NCT06593405
Phase
EARLY_PHASE1
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 100 Years
Healthy Volunteers
Accepted

Interventions

  • occupational therapy interventions for low vision care — COMBINATION_PRODUCT
    Occupational therapists utilize many different treatment strategies when caring for the client with low vision. Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Interventions include task lighting, organizational strategies, smart apps, contrast, enlarged print, typoscopes and electronic magnification devices.

Study Details

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are: Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task? Participants will: Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

Key Dates

Start date
Apr 22, 2025
Status verified
May 2026
Primary completion
Dec 5, 2026
Completion
Dec 5, 2026

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Receiving OT interventions
    All participants will receive all OT interventions

Primary Outcome Measure

Revised Self Report Assessment of Functional Visual [ Time Frame: Results from the Revised-Self-Report Assessment of Functional Visual Performance assessment will be determined on day 1 and 4 weeks later ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MCPHS 10 Lincoln SquareWorcesterMassachusetts01608
Michelle Dowling, Clinical Doctorate (OTD)
508-373-5851
Michelle Dowling, Clinical Doctorate (PRINCIPAL_INVESTIGATOR)

Find similar trials in Worcester, MA

Related Studies